Welcome to an AstraZeneca UK produced and funded website
Please select the option that applies to you below.
GB-51556 | DOP: March 2024
For UK patients, and their caregivers, aged 12 and over who have been prescribed Tezspire (tezepelumab) for severe uncontrolled asthma
For more information read the patient information leaflet accessible here
For UK patients, and their caregivers, aged 12 and over who have been prescribed Tezspire▼ (tezepelumab) for severe uncontrolled asthma
For more information read the patient information leaflet accessible here
Connect 360 is a patient support programme for people who have been prescribed Tezspire for their severe asthma when it is not controlled by other medicines. Connect 360 is here to help you manage your condition, achieve your health goals and get the most out of your treatment with Tezspire. Please note this website is here to complement the advice of your doctor, pharmacist or nurse, not replace it. Please always follow their instructions first and foremost, and talk with them about any questions or concerns you have about your health and treatment.
The Connect 360 service helps you stay on track with your Tezspire treatment with a home delivery service, as well as information on how Tezspire works and help with self-injection.
Tezspire may help to reduce your number of asthma attacks, improve your breathing and ease your asthma symptoms. Tezspire should be given as an injection under the skin (subcutaneously) once every 28 days. The injection can either be given by a doctor, nurse, or caregiver, or you can learn to do this yourself after proper training on the preparation and administration.
What are you looking for today?
Reporting side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.ukhttps://yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.
This site is intended to complement, not replace, the 'Instructions for Use' and 'Patient Information Leaflet' (found in your carton or linked at the top of the page). Refer to these materials for additional important information.
If you have any questions or concerns about your treatment, you should always talk to your healthcare team.
Please see the information in the box above for details on how to report any side effects you may be experiencing.
